0.0002USD-33.33%Mkt Cap: 46473 USDP/E: —Last update: 2026-05-22
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidat…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap46.47K USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.48M USD
Revenue/Share—
Last Price0.0002 USD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-0.91
EPS (Forward)-0.89
52W Range
0.00001% of range0.0150
52W High0.0150 USD
52W Low0.0000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE9.71%
ROA-1051.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.18M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-11500.49%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.17
Current Ratio0.06
Quick Ratio—
Book Value/Sh-0.5570 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.232.37M
Float208.41M
Insiders10.31%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Float2.05%
Short % Out.1.77%
Shares Short2.93M
Short (prev mo.)5.72M
Technical
SMA 500.0004 (-49.5%)
SMA 2000.0020 (-90.1%)
Beta-0.07
S&P 52W Chg28.31%
Avg Vol (30d)64.51K
Avg Vol (10d)79.27K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—